Mutations at the M2 and M3 Transmembrane Helices of the GABA(A)Rs α(1) and β(2) Subunits Affect Primarily Late Gating Transitions Including Opening/Closing and Desensitization

GABA(A)受体α(1)和β(2)亚基M2和M3跨膜螺旋的突变主要影响晚期门控转换,包括开放/关闭和脱敏。

阅读:1

Abstract

GABA type A receptors (GABA(A)Rs) belong to the pentameric ligand-gated ion channel (pLGIC) family and play a crucial role in mediating inhibition in the adult mammalian brain. Recently, a major progress in determining the static structure of GABA(A)Rs was achieved, although precise molecular scenarios underlying conformational transitions remain unclear. The ligand binding sites (LBSs) are located at the extracellular domain (ECD), very distant from the receptor gate at the channel pore. GABA(A)R gating is complex, comprising three major categories of transitions: openings/closings, preactivation, and desensitization. Interestingly, mutations at, e.g., the ligand binding site affect not only binding but often also more than one gating category, suggesting that structural determinants for distinct conformational transitions are shared. Gielen and co-workers (2015) proposed that the GABA(A)R desensitization gate is located at the second and third transmembrane segment. However, studies of our and others' groups indicated that other parts of the GABA(A)R macromolecule might be involved in this process. In the present study, we asked how selected point mutations (β(2)G254V, α(1)G258V, α(1)L300V, and β(2)L296V) at the M2 and M3 transmembrane segments affect gating transitions of the α(1)β(2)γ(2) GABA(A)R. Using high resolution macroscopic and single-channel recordings and analysis, we report that these substitutions, besides affecting desensitization, also profoundly altered openings/closings, having some minor effect on preactivation and agonist binding. Thus, the M2 and M3 segments primarily control late gating transitions of the receptor (desensitization, opening/closing), providing a further support for the concept of diffuse gating mechanisms for conformational transitions of GABA(A)R.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。